Atlas Trials

Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers

Clinical trial NCT00660153 · COMPLETED

Trial details

NCT number
NCT00660153
Sponsor
AVEO Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal CancerGastrointestinal Cancer
Start date
2008-06-01
Primary completion
2012-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.